Erratum: Generation of the SCN1A epilepsy mutation in hiPS cells using the TALEN technique (Scientific Reports (2015) 4 (5404) DOI: 10.1038/srep05404);Generation of the SCN1A epilepsy mutation in hiPS cells using the TALEN technique

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Wanjuan ^a   Liu, Jingxin ^b   Zhang, Longmei ^b   Xu, Huijuan ^c   Guo, Xiaogang ^c   Deng, Sihao ^d   Liu, Lipeng ^e   Yu, Daiguan ^c   Chen, Yonglong ^c   Li, Zhiyuan ^c,d  

^a ANHUI UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Central South University   (China)

^e Xiang Ya Boai Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; SCN1A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.1;

CELL CULTURE; CYTOLOGY; EPILEPSY; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; MUTATION; PHYSIOLOGY; PROCEDURES; PROTEIN ENGINEERING; SITE DIRECTED MUTAGENESIS;

CELLS, CULTURED; DEOXYRIBONUCLEASES; EPILEPSY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; PROTEIN ENGINEERING;

EID: 84903171249     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11174     Document Type: Erratum

References (21)

1. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30, 389-399 (1989).
2. Claes, L. et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68, 1327-1332, doi:10.1086/320609 (2001).
3. Sugawara, T. et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58, 1122-1124 (2002).
4. Catterall, W. A., Kalume, F. & Oakley, J. C. NaV1.1 channels and epilepsy. J Physiol 588, 1849-1859, doi:10.1113/jphysiol.2010.187484 (2010).
5. Sugawara, T. et al. Nav1. 1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents. Epilepsy Res 54, 201-207 (2003).
6. Yu, F. H. et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9, 1142-1149, doi:10.1038/nn1754 (2006).
7. Kalume, F., Yu, F. H., Westenbroek, R. E., Scheuer, T. & Catterall, W. A. Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 27, 11065-11074, doi:10.1523/JNEUROSCI.2162-07.2007 (2007).
8. Cermak, T. et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39, e82, doi:10.1093/nar/gkr218 (2011).
9. Bogdanove, A. J., Schornack, S. & Lahaye, T. TAL effectors: finding plant genes for disease and defense. Curr Opin Plant Biol 13, 394-401, doi:10.1016/j.pbi.2010.04.010 (2010).
10. Stoddard, B. L. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 19, 7-15, doi:10.1016/j.str. 2010.12.003 (2011).
11. Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S. & Gregory, P. D. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11, 636-646, doi:10.1038/nrg2842 (2010).
12. Peitz, M., Jungverdorben, J. & Brustle, O. Disease-specific iPS cell models in neuroscience. Curr Mol Med 13, 832-841 (2013).
13. Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221, doi:10.1126/science.1158799 (2008).
14. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi:10.1016/j.cell.2007.11. 019 (2007).
15. Daley, G. Q. & Scadden, D. T. Prospects for stem cell-based therapy. Cell 132, 544-548, doi:10.1016/j.cell.2008.02.009 (2008).
16. Soldner, F. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318-331, doi:10.1016/j.cell.2011.06.019 (2011).
17. Li, W. et al. Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet 21, 32-45, doi:10.1093/hmg/ddr435 (2012).
18. Jiao, J. et al. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. Hum Mol Genet 22, 4241-4252, doi:10.1093/hmg/ddt275 (2013).
19. Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923, doi:10.1126/science.1152092 (2007).
20. Lei, Y. et al. Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs). Proc Natl Acad Sci USA 109, 17484-17489, doi:10.1073/pnas.1215421109 (2012).
21. Shi, Y., Kirwan, P. & Livesey, F. J. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 7, 1836-1846, doi:10.1038/nprot.2012.116 (2012).